Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Cyanotech Corporation (CYAN : OTC)
 
 • Company Description   
CYANOTECH CORP. develops and commercializes natural products from microalgae. Co. is currently producing microalgae products for the nutritional supplement and immunological diagnostics markets and is also developing microalgae-based products for the aquaculture feed/pigments, biopesticide and food coloring markets. Microalgae are a diverse group of over 30,000 species of microscopic plants which have a wide range of physiological and biochemical characteristics and naturally contain high levels of nutrients.

Number of Employees: 83

 
 • Price / Volume Information   
Yesterday's Closing Price: $0.46 Daily Weekly Monthly
20 Day Moving Average: 4,437 shares
Shares Outstanding: 7.23 (millions)
Market Capitalization: $3.33 (millions)
Beta: -0.30
52 Week High: $0.89
52 Week Low: $0.23
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 11.92% 7.73%
12 Week 36.74% 15.02%
Year To Date 26.10% 18.09%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
73-4460 QUEEN KAAHUMANU HWY SUITE 102
-
KAILUA KONA,HI 96740
USA
ph: 808-326-1353
fax: 808-329-4533
brussell@cyanotech.com http://www.cyanotech.com
 
 • General Corporate Information   
Officers
Matthew K. Custer - Chief Executive Officer and President
Michael A. Davis - Chairman
Jennifer C. Rogerson - Chief Financial Officer; Vice President and Treasu
David M. Mulder - Director
David L. Vied - Director

Peer Information
Cyanotech Corporation (GSAC)
Cyanotech Corporation (CASI)
Cyanotech Corporation (ALCD.)
Cyanotech Corporation (OMNN)
Cyanotech Corporation (CGPI.)
Cyanotech Corporation (CATX)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-DRUGS
Sector: Medical
CUSIP: 232437301
SIC: 2833
Fiscal Year
Fiscal Year End: March
Last Reported Quarter: 03/01/25
Next Expected EPS Date: 08/06/25
Share - Related Items
Shares Outstanding: 7.23
Most Recent Split Date: 11.00 (0.25:1)
Beta: -0.30
Market Capitalization: $3.33 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/06/25  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 0.37
Price/Cash Flow: -
Price / Sales: 0.14
EPS Growth
vs. Year Ago Period: 70.00%
vs. Previous Quarter: -200.00%
Sales Growth
vs. Year Ago Period: 5.53%
vs. Previous Quarter: 2.07%
ROE
06/30/25 - -
03/31/25 - -33.08
12/31/24 - -44.71
ROA
06/30/25 - -
03/31/25 - -13.38
12/31/24 - -19.12
Current Ratio
06/30/25 - -
03/31/25 - 1.03
12/31/24 - 1.06
Quick Ratio
06/30/25 - -
03/31/25 - 0.27
12/31/24 - 0.28
Operating Margin
06/30/25 - -
03/31/25 - -13.23
12/31/24 - -19.50
Net Margin
06/30/25 - -
03/31/25 - -13.23
12/31/24 - -19.50
Pre-Tax Margin
06/30/25 - -
03/31/25 - -13.19
12/31/24 - -19.48
Book Value
06/30/25 - -
03/31/25 - 1.23
12/31/24 - 1.33
Inventory Turnover
06/30/25 - -
03/31/25 - 2.34
12/31/24 - 2.48
Debt-to-Equity
06/30/25 - -
03/31/25 - 0.11
12/31/24 - 0.11
Debt-to-Capital
06/30/25 - -
03/31/25 - 10.12
12/31/24 - 9.52
 

Powered by Zacks Investment Research ©